Nobivac NXT Canine Flu H3N2, 25x1ds- COMING SOON!
INV214944
Nobivac NXT vaccine delivers RNA particles to harness the natural ability of the immune system to generate a robust response with no compromise to safety or comfort.
Features:
- Delivers the desired viral sequence to dendritic cells for an enhanced, precise immune response
- NXT-level protection in a preservative-free, adjuvant-free, thimerosal-free formulation
- A low-volume 0.5ml dose for a more gentle vaccine
- Self-amplification triggers a robust antibody and cellular immune response without the use of an adjuvant or live organism
Administration:
- For primary immunization, administer 1 dose (0.5ml) subcutaneously as early as 8 weeks of age followed by a second dose 3-4 weeks later
Indication:
- Effective for dogs 8 weeks of age or older against canine influenza virus H3N2
Sold in a tray of 25
Related Documents
INV214944
Nobivac NXT Canine Flu H3N2, 25x1ds- COMING SOON!
/PennVet Catalog/TX - Product Categories/88 - Vaccines/7 - Vaccines/1 - Canine/8 - Influenza
/PennVet Catalog/TX - Manufacturers/MERCK - Merck Animal Health
Product Detail Page